fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » TATA India PHARMA Healthcare Fund

TATA India PHARMA & Healthcare Fund - G

NAV  ₹13.5461 ↓ -0.01  (-0.10 %) as on 20 Oct 20

Scheme Objective

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund launched on 28 Dec 15. It is a fund with High risk and has given a CAGR return of 6.5% since its launch.  Return for 2019 was 5.5% , 2018 was -2.6% and 2017 was 4.7% .

Below is the key information for TATA India Pharma & Healthcare Fund

NAV as on 20 Oct 20₹13.5461 ↓ -0.01  (-0.10 %)
Net Assets (AUM) as on 30 Sep 2020 ₹337 Cr.
Launch Date28 Dec 2015
CategoryEquity - Sectoral
RatingNot Rated
TypeOpen Ended Fund
RiskHigh
AMCTata Asset Management Limited
Alpha Ratio9.46
Expense Ratio2.61 %
Sharpe Ratio1.676
Information Ratio0.82
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 20 Oct 20

DurationReturns
1 Month -3.2%
3 Month 17.6%
6 Month 26.7%
1 Year 52.6%
3 Year 16.6%
5 Year
10 Year
15 Year
Since launch 6.5%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%
2015
2014
2013
2012
2011

Growth of 10k Over Years

DateValue
30 Sep 16₹9,501
30 Sep 17₹8,151
30 Sep 18₹9,101
30 Sep 19₹8,790
30 Sep 20₹13,560
TATA India PHARMA & Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash3.44%
Equity96.56%
TATA India PHARMA & Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care96.56%
TATA India PHARMA & Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | 500124
Drug Manufacturers - Specialty & Generic15%₹52 Cr100,300
↓ -14,000
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
Drug Manufacturers - Specialty & Generic10%₹35 Cr690,100
↓ -180,000
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 500087
Drug Manufacturers - General9%₹32 Cr410,000
↑ 42,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic8%₹28 Cr92,500
↓ -10,000
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 524494
Drug Manufacturers - Specialty & Generic7%₹24 Cr109,500
↑ 14,500
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 29 Feb 20 | NH
Medical Care Facilities7%₹22 Cr626,720
↑ 200,000
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 500257
Drug Manufacturers - Specialty & Generic6%₹20 Cr203,000
↑ 25,000
Laurus Labs Ltd (Healthcare)
Equity, Since 31 Jul 20 | 540222
Drug Manufacturers - Specialty & Generic5%₹16 Cr560,000
↑ 245,000
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500126
Drug Manufacturers - Specialty & Generic4%₹13 Cr26,000
Indoco Remedies Ltd (Healthcare)
Equity, Since 30 Jun 20 | 532612
Drug Manufacturers - Specialty & Generic3%₹11 Cr445,000
↑ 265,000
1 - 10 of 23
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Rahul Singh20 Apr 200.45 Yr.
Meeta Shetty20 Apr 200.45 Yr.

Custodians

CompanyAddress
Deutsche Bank AGDeutsche Bank AG,Kodak House, 22, D.N. Road,

Registrar & Transfer Agent

Computer Age Management Services Ltd
AddressNew No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam
FAX91-44-28283610
Emailenq_L@camsonline.com

Administrator Companies

CompanyAddress
Tata Mutual Fund1903, B-Wing, Parinee Crescenzo,,G-Block, Bandra Kurla Complex, Bandra East Mumbai 400051

Auditors

CompanyAddress
Deloitte Haskins & Sells12, Dr. Annie Besant Road, Opp. Shiv Sagar Estate,,Worli
M/s BSR & Co.KPMG House, Kamala Mills Compound,448 Senapati Bapat Marg,Lower Parel

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
TATA India Pharma & Healthcare Fund
Normal Dividend, Reinvestment
₹13.5461
↓ -0.01
26.65 %52.63 %16.61 %-
TATA India Pharma & Healthcare Fund
Normal Dividend, Payout
₹13.5461
↓ -0.01
26.65 %52.63 %16.61 %-
TATA India Pharma & Healthcare Fund
Growth
₹13.5461
↓ -0.01
26.65 %52.63 %16.61 %-
Data as on 20 Oct 20

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.